| Betaseron/Betaferon - multiple sclerosis encyclopaedia Multiple Sclerosis Encyclopaedia - Betaseron/Betaferon ... Betaseron, known as Betaferon in Europe, is manufactured by Schering and its US associate Berlex. Read More |
| BETASERON® Official Website Whether considering, about to start taking, or already taking BETASERON (interferon beta-1b), you'll find detailed information and support to help you understand ... Read More |
| Interferon beta-1b - Wikipedia, the free encyclopedia Interferon beta-1b (tradenames Betaferon, Betaseron (North America), Extavia and ZIFERON) is a drug in the interferon family used to treat the relapsing-remitting and ... Read More |
| BETAFERON - Domain Registration Betaferon: One 3 mL vial contains interferon beta-1b 9,6 million IU (0,3 mg) per vial as a lyophilised cake. (This includes an overfill of 20%, so ... Read More |
| Betaferon | Drugs.com Patient information for Betaferon including dosage instructions and side effects. Read More |
| Betaferon - European Drugs Reference Encyclopedia Betaferon, - European Drugs Reference Encyclopedia ... Summary for the public What is Betaferon? Betaferon is a powder and solvent, which is made into a solution for ... Read More |
| Betaferon® - MS Australia Betaferon® This section does not contain all the available information regarding drug therapy. It does not take the place of talking to your neurologist, general ... Read More |
| Multiple Sclerosis Portal Overview - MS Gateway - The Multiple ... Welcome to our Multiple Sclerosis Communities worldwide - the MS-Gateway Community-network! Read More |
| Betaferon - Interferon beta-1b - Medical Drug Betaferon (interferon-1b) is a specially modified preparation of the cytokine interferon beta. Betaferon is indicated for the treatment of ambulatory patients with ... Read More |
| European Medicines Agency - Find medicine - Betaferon This is a summary of the European public assessment report (EPAR) for Betaferon. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed ... Read More |
